ALKS 3831, a combination of olanzapine and samidorphan, has no clinically relevant effect on QT prolongation up to supratherapeutic doses
CLINICAL PHARMACOLOGY & THERAPEUTICS(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CLINICAL PHARMACOLOGY & THERAPEUTICS(2019)